Ascendis Pharma A/S (BVMF:A1SN34)
Brazil flag Brazil · Delayed Price · Currency is BRL
76.05
-2.52 (-3.21%)
At close: Mar 24, 2026

Ascendis Pharma Ratios and Metrics

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
68,08965,11440,98535,43833,99036,658
Market Cap Growth
-58.87%15.65%4.26%-7.28%-17.80%
Enterprise Value
69,59163,76839,97834,46832,64233,354
PE Ratio
--48.34-20.26-13.33-10.95-16.90
PS Ratio
14.6215.4921.7724.16124.47833.13
PB Ratio
-64.66-68.52-74.90-44.2324.197.33
P/TBV Ratio
-28.71-79.37-75.40-48.6626.018.34
P/FCF Ratio
231.85245.65-25.74-13.72-12.48-14.68
P/OCF Ratio
195.35206.98-25.86-13.79-12.85-15.52
EV/Sales Ratio
16.4515.1721.2423.50119.53758.03
EV/EBITDA Ratio
--92.14-29.58-14.35-11.25-13.51
EV/EBIT Ratio
--80.17-27.70-13.76-10.89-13.05
EV/FCF Ratio
236.96240.57-25.10-13.34-11.99-13.36
Debt / Equity Ratio
-2.37-2.37-3.45-1.531.830.11
Debt / EBITDA Ratio
-7.35-7.35-3.28-1.48-0.93-0.24
Debt / FCF Ratio
19.2019.20-2.78-1.37-1.00-0.24
Net Debt / Equity Ratio
-1.57-1.57-2.81-1.68-0.86-0.65
Net Debt / EBITDA Ratio
-2.16-2.16-1.14-0.560.421.32
Net Debt / FCF Ratio
5.635.63-0.97-0.520.451.31
Asset Turnover
0.580.580.360.280.050.01
Inventory Turnover
0.010.320.18-0.260.120.09
Quick Ratio
0.720.720.810.624.447.03
Current Ratio
1.041.041.170.955.398.03
Return on Equity (ROE)
169.84%169.84%300.78%-818.43%-101.69%-44.54%
Return on Assets (ROA)
-11.77%-11.77%-28.17%-48.30%-52.15%-43.72%
Return on Invested Capital (ROIC)
-26.11%-26.11%-66.04%-158.18%-190.06%-154.96%
Return on Capital Employed (ROCE)
-53.99%-53.99%-154.56%-90.43%-59.04%-47.27%
Earnings Yield
-2.17%-2.07%-4.94%-7.50%-9.13%-5.92%
FCF Yield
0.43%0.41%-3.89%-7.29%-8.01%-6.81%
Buyback Yield / Dilution
-4.69%-4.69%-2.85%-0.38%-2.37%-8.21%
Total Shareholder Return
-4.69%-4.69%-2.85%-0.38%-2.37%-8.21%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.